What does BIOINDUSTRIAL SCALE-UP FOR SUPPLY CHAINS AND ENERGY RESILIENCY. of Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 do?

This section amends the Energy Policy Act of 2005 to establish bioindustrial technology maturation facilities. The Secretary shall establish at least 2 facilities to conduct research, development, and demonstration of bioindustrial manufacturing technologies. The facilities will operate as user facilities available to governmental and nongovernmental users. The Secretary shall submit a strategic plan for the implementation of this subsection, including an assessment of capacity scaling needs and a description of each covered facility. The facilities will focus on bioindustrial manufacturing, including the use of living organisms to produce materials and products.

Back to bills

Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026

Q: What does Preamble of Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 do?

This bill amends the Energy Policy Act of 2005. The bill aims to support the development, demonstration, and commercial application of biotechnology products. The stated purpose is to increase energy resiliency.

Q: What does SHORT TITLE. of Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 do?

This bill is formally titled the Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026

Q: What does SENSE OF CONGRESS. of Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 do?

This section expresses the sense of Congress regarding biotechnology innovation and commercialization. A primary obstacle to commercialization for U.S. biotechnology innovators is demonstrating the scalability of their products and processes to attract investors. The United States faces challenges in securing the infrastructure needed for biotechnology product breadth, including insufficient biomanufacturing capacity. Current biomanufacturing facilities are often optimized for a single product and lack compatibility with others. Congress believes establishing technology maturation facilities with world-class capabilities is critical to maintaining U.S. leadership in bioindustrial innovation.

Last updated: 3/16/2026 · Introduced: 3/16/2026

Author: James Baird (R-IN)

TL;DR (AI)

The bill establishes bioindustrial technology maturation facilities to conduct research, development, and demonstration of bioindustrial manufacturing technologies.
At least two facilities will be established to operate as user facilities available to governmental and nongovernmental users, focusing on bioindustrial manufacturing.
The bill aims to increase energy resiliency by supporting the development, demonstration, and commercial application of biotechnology products.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 2 more.

4 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account